Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Contributed by: ACCESSWIRE

Logo

Tags

Champions Oncology, Inc.

Healthcare & Pharmaceutical

NASDAQ:CSBR

Product Announcements

More Like This

Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations